There are only twelve days until Sept. 30, the end of the fiscal year — the point at which the FDA faces potentially laying off thousands of employees if user fee legislation isn’t reauthorized by Congress — and yet Congress still has not completed the vital legislation.
Source: Drug Industry Daily